L

LVTX

Lava Therapeutics Bv

1.24

-0.04-3.13%
Closed14:12 05/05 EDT

Financial Statements

Statement:

Key indicator

Income Statement

Balance Sheet

Cash Flow

Reporting Period:

Accumulated Report

FY

YoY:
FY: Financial Year Annual Report
Q: Quarter is quarterly reports. Q1, Q2, Q3 and Q4 are reports for a single quarter. Q6 and Q9 are accumulated quarterly reports, respectively contain 6 months' reports and 9 months' report.
Item
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Cash from Operating Activities

-19.54M

-40.28M

4.04M

-28.65M

-8.46M

Net Income

-25.11M

-41.87M

-31.66M

-45.19M

-13.55M

Depreciation/Depletion & Amortization

467.00K

612.00K

781.00K

558.00K

185.00K

Deferred Taxes

-10.00K

0

--

--

--

Non-Cash Items

730.00K

4.85M

807.00K

5.15M

1.12M

Changes in Working Capital

4.38M

-3.88M

34.11M

10.84M

3.78M

Cash from Investing Activities

12.47M

-17.64M

9.35M

-43.55M

-437.00K

Capital Expenditures

-23.00K

-731.00K

-587.00K

-764.00K

-437.00K

Other Investing Cash Flow Items, Total

12.50M

-16.91M

9.93M

-42.78M

0

Cash from Financing Activities

-569.00K

0

283.00K

151.16M

16.04M

Financing Cash Flow Items

--

--

--

61.80M

18.53M

Total Cash Dividends Paid

--

--

--

--

--

Issuance (Retirement) of Stock, Net

27.00K

0

15.00K

89.02M

-4.08M

Issuance (Retirement) of Debt, Net

-596.00K

0

268.00K

340.00K

1.59M

Foreign Exchange Effects

-1.58M

1.82M

-4.21M

-3.92M

-805.00K

Net Change in Cash

-9.22M

-56.10M

9.46M

75.05M

6.34M

Cash Interest Paid

--

--

--

--

--

Cash Taxes Paid

283.00K

355.00K

--

--

--